40048 Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Cryptosporidium are a genus of 

parasites that cause the diarrheal 

disease cryptosporidiosis. As part of 

Cryptosporidium case and outbreak 

investigations, it is common for state 

and local health departments to conduct 

comprehensive interviews with cases 

and contacts to identify how individuals 

became sick with cryptosporidiosis, to 

identify individuals who could have 

come into contact with an individual 

sick with cryptosporidiosis, and to 

identify strategies to control the disease 

spread. Since cryptosporidiosis can be 

transmitted through numerous modes, it 

can be challenging to identify how 

individuals could have become ill. As a 

result, comprehensive case report forms 

focused on a range of settings, activities, 

and potential modes of transmission are 

needed to guide prevention and control 

activities. 

The CryptoNet case report form (CRF) 

was developed to meet the needs of 

CDC’s case surveillance experts and 

local officials. The CRF includes a set of 

data elements that can be used to 

identify exposure trends in outbreakand non-outbreak-associated 

Cryptosporidium cases, to generate 

hypotheses about the source(s) of 

infection in clusters or outbreaks, and to 

identify strategies to prevent and control 

Cryptosporidium cases, clusters, or 

outbreaks. CryptoNet is meant to 

supplement existing cryptosporidiosis 

case surveillance data reported through 

the National Notifiable Diseases 

Surveillance System (NNDSS) (OMB 

No. 0920–0728, Exp. 3/31/2024). 

Current cryptosporidiosis case 

surveillance through NNDSS lacks 

information on key exposures proposed 

to be captured by CryptoNet. Notably, 

information proposed to be collected as 

part of CryptoNet serves as the 

foundation for the recently developed 

foodborne and diarrheal diseases 

message mapping guide— 

cryptosporidiosis tab (FDD MMG). The 

FDD MMG is the latest revision to 

NNDSS that aims to increase the 

amount of exposure data collected on 

each cryptosporidiosis case. Upon 

nationwide implementation of the FDD 

MMG, NCEZID anticipates that the 

CryptoNet Case Report form will be 

retired. 

Administration of the CRF is to 

conduct surveillance on exposures 

associated with Cryptosporidium cases 

to better inform prevention and control 

strategies for these infections. There are 

no research questions addressed. 

Standardized data will be compiled on 

recent exposures related to 

cryptosporidiosis with the intention to 

inform disease prevention and control 

activities and will not be used to inform 

generalizable knowledge. CDC’s 

CryptoNet staff and the Case 

Surveillance node in CDC’s Waterborne 

Disease Prevention Branch (WDPB) will 

oversee data collection, data 

management, and analyses and 

dissemination of data collected with the 

CRF during cryptosporidiosis 

investigations. The data collected from 

the CRF will be used to inform exposure 

trends among cases, clusters, or 

outbreaks with the intention to identify 

and implement prevention and control 

strategies and recommendations. 

The CRF data elements and form were 

designed for administration via 

telephone interview with cases of 

cryptosporidiosis or their proxies. This 

method was chosen to reduce the 

overall burden on respondents because 

it allows for the assessment team to ask 

for clarification from participants during 

the interview, and this limits the need 

for additional follow-up. The data 

collection instrument was designed to 

collect the minimum information 

necessary for the purposes of this 

project. 

Based on the annual number of 

laboratory specimens collected by the 

Cryptosporidium laboratory at CDC, it is 

expected that an average of 500 

CryptoNet CRFs will be collected each 

year. OMB approval is requested for 

three years. Participation is voluntary 

and there are no costs to respondents 

other than their time. The total 

estimated annualized burden is 125 

hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Individuals ill with Cryptosporidiosis, or their 

designated proxy.

CryptoNet Case Report Form ........................ 500 1 15/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–15790 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1169] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Development 

of CDC’s Let’s Stop HIV Together Social 

Marketing Campaign for Consumers’’ to 

the Office of Management and budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on March 12, 2021 to obtain 

comments from the public and affected 

agencies. CDC did not receive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 40049 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Development of CDC’s Let’s Stop HIV 

Together Social Marketing Campaign for 

Consumers—Reinstatement—National 

Center for HIV/AIDS, Viral Hepatitis, 

STD and TB Prevention (NCHHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

To address the HIV epidemic in the 

U.S., the Department of Health and 

Human Services launched Ending the 

HIV Epidemic: A Plan for America, 

which is a cross-agency initiative 

aiming to reduce new HIV infections in 

the U.S. by 90% by 2030. CDC’s Let’s 

Stop HIV Together campaign (formerly 

known as Act Against AIDS) is part of 

the national Ending the HIV Epidemic 

initiative and includes resources aimed 

at reducing HIV stigma and promoting 

testing, prevention, and treatment across 

the HIV care continuum. 

Within this context, CDC’s Division of 

HIV/AIDS Prevention (DHAP) has and 

will continue implementing various 

communication initiatives to increase 

HIV awareness among the general 

public, reduce new HIV infections 

among disproportionately impacted 

populations, and improve health 

outcomes for people living with HIV/ 

AIDS in the US and its territories. 

Specifically, the campaigns target 

consumers aged 18 to 64 years old and 

includes the following audiences: (1) 

General public; (2) Men who have sex 

with men; (3) Blacks/African 

Americans; (4) Hispanics/Latinos; (5) 

Transgender individuals; (6) people 

who inject drugs; and (7) people with 

HIV (PWH). 

The rounds of data collection include 

exploratory, message testing, concept 

testing, and materials testing. 

Information collected by DHAP will be 

used to assess consumers’ informational 

needs about HIV testing, prevention, 

and treatment and pre-test campaign 

related messages, concepts, and 

materials and evaluate the extent to 

which the communication initiatives are 

reaching the target audiences and 

providing them with trusted HIV-related 

information. Data collections will 

include in-depth interviews, focus 

groups, brief surveys, and intercept 

interviews. 

The data gathered under this request 

will be summarized in reports prepared 

for CDC by its contractor, such as 

quarterly and annual reports and topline 

reports that summarize results from 

each data collection. It is possible that 

data from this project will be published 

in peer-reviewed manuscripts or 

presented at conferences; the 

manuscripts and conference 

presentations may appear on the 

internet. 

The total estimated annualized 

burden hours are 1,856. Participation by 

respondents is voluntary, and there is 

no cost to participants other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Health care providers.Study screener ........................................................................................ 2,165 1 2/60 

Exploratory—HIV Testing In-depth Interview .......................................... 50 1 1 

Exploratory—HIV Prevention In-depth Interview .................................... 52 1 1 

Exploratory—HIV Communication and Awareness In-depth Interview .. 50 1 1 

Exploratory—HIV Prevention with Positives In-depth Interview ............. 50 1 1 

Message Testing In-depth Interview ....................................................... 50 1 1 

Concept Testing In-depth Interview ........................................................ 50 1 1 

Materials Testing In-depth Interview ....................................................... 50 1 1 

Exploratory—HIV Testing Focus Group .................................................. 74 1 2 

Exploratory—HIV Prevention Focus Group ............................................ 74 1 2 

Exploratory—HIV Communication and Awareness Focus Group .......... 74 1 2 

Exploratory—HIV Prevention with Positives Focus Group ..................... 74 1 2 

Concept Testing Focus Group ................................................................ 68 1 2 

Message Testing Focus Group ............................................................... 68 1 2 

Materials Testing Focus Group ............................................................... 68 1 2 

HIV Testing Survey ................................................................................. 213 1 15/60 

HIV Prevention Survey ............................................................................ 213 1 15/60 

HIV Communication and Awareness Survey .......................................... 213 1 15/60 

HIV Prevention with Positives Survey ..................................................... 213 1 15/60 

Intercept Interview ................................................................................... 657 1 20/60 


jbell on DSKJLSW7X2PROD with NOTICES
40050 Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–15792 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–0800; Docket No. CDC–2021– 

0072] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communication Campaigns. 

CDC is requesting a Revision to this 

Generic Clearance to include an 

additional cancer-related 

communications campaign, expand the 

modes of data collection to include 

online focus groups and in-depth 

interviews (in-person, phone, and 

online), and to focus on respondents 

from the general public. 

DATES: CDC must receive written 

comments on or before September 24, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0072 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communications Campaigns— 

(OMB Control No. 0920–0800, Exp. 10/ 

31/2021)—Revision—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The mission of the CDC’s Division of 

Cancer Prevention and Control (DCPC) 

is to reduce the burden of cancer in the 

United States through cancer 

prevention, reduction of risk, early 

detection, and improved quality of life 

for cancer survivors. Toward this end, 

the DCPC supports the scientific 

development and implementation of 

various health communication 

campaigns with an emphasis on specific 

cancer burdens. 

This process requires testing of 

messages, concepts, and materials prior 

to their final development and 

dissemination, as described in the 

second step of the health 

communication process. The health 

communication process is a scientific 

model developed by the U.S. 

Department of Health and Human 

Services’ National Cancer Institute to 

guide sound campaign development. 

The communication literature supports 

various data collection methods to 

conduct credible formative, concept, 

message, and materials testing. This 

process ensures that the public clearly 

understands cancer-specific information 

and concepts, are motivated to take the 

desired action, and do not react 

negatively to the messages. CDC is 

currently approved to collect 

information needed to plan and tailor 

cancer communication campaigns (OMB 

Control No. 0920–0800, Exp. 10/31/ 

2021), and seeks OMB approval to 

revise the existing generic clearance to 

include another cancer-related 

communications campaign, expand the 

modes of data collection to include 

online focus groups and in-depth 

interviews (in-person, phone, and 

online), and to focus on respondents 

from the general public. 

Information collection will involve 

discussions to assess numerous 

qualitative dimensions of cancer 

prevention and control messages 

including, but not limited to, cancer 

knowledge, attitudes, beliefs, behavioral 

intentions, information needs and 

sources, and compliance with cancer 

screening as recommended by the 

United States Preventive Services Task 

Force. Insights gained from these 

discussions will assist in the 

development and/or refinement of 

future campaign messages and 

materials. Communication campaigns 

and messages will vary according to the 

type of cancer and the qualitative 

dimensions of the message described 

above. A separate information collection 


jbell on DSKJLSW7X2PROD with NOTICES